O execute da mel vai acabar tomand onerf dnv pois ainda é extremamente roubado. Não deveriam ter acabado com o W da coitada.

Thinking creatively about thin-film electrodes. Learn how @N1MTC has developed an automated photolithography process to manufacture thin-film electrodes for its OneRF Ablation System, enabling more precise and minimally invasive treatment: buff.ly/cKPL4tQ #tmdmag #medtech

@N1MTC is proud to highlight the scientific and clinical posters related to the OneRF® Ablation System and other NeuroOne products in development. These will be presented at the American Association of Neurological Surgeons (AANS) 2026 Annual Meeting. (Caution: RxOnly)

NeuroOne Medical Technologies Corporation CEO Dave Rosa Featured on Xtalks Life Science Podcast Watch the Interview Here: ow.ly/b9ZK50YQHf8 $NMTC #NeuroOne #OneRF® @N1MTC ir.nmtc1.com

NeuroOne® to Host Virtual Investor Webinar on Thursday, March 12, 2026 at 11:30 AM ET ow.ly/zTV050YmpvQ Dial-In: 888-506-0062 Int'l: 973-528-0011 Access Code: 358063 Webcast: ow.ly/r2et50YmpvS $NMTC #NeuroOne #OneRF® @N1MTC ir.nmtc1.com

Thanks @Lisa_Fielding & @MSN for sharing Mark’s journey—from seizure disorder to back on stage after OneRF® ablation at @MayoClinic. (Caution: RxOnly) Disclaimer: This recounts one patient's experience and may not be representative of all patient outcomes. tinyurl.com/bdze8z2w

Trigeminal neuralgia is a debilitating condition that causes electric shock–like facial pain. University Hospitals is the first health system in the world to offer a new type of minimally-invasive treatment with the OneRF® Trigeminal Nerve Ablation System. bit.ly/NerveAblationX126

@N1MTC is excited to announce first cases with the recently cleared OneRF® Trigeminal Nerve Ablation System (Caution: Rx Only) at the @UHhospitals in Cleveland. We thank @StaudtMD and his team for providing this latest innovation for the care of their patients.

@N1MTC is proud to highlight the Scientific/Clinical Posters related to the OneRF® Ablation System and other NeuroOne products in development that will be presented at @AmEpilepsySoc #AES2025 Annual Meeting taking place December 5-9, 2025 (Caution: RxOnly).

See the OneRF® Ablation System in action. Our FDA-cleared system offers a minimally invasive, bedside approach to nervous tissue ablation for patients with seizures associated with #epilepsy. (RxOnly)

Great talk on the @N1MTC OneRF system for radio frequency ablation in epilepsy by Aura Kullman @CNS_Update and great patient outcome for @SeizureSurgeon @neurosurgery

Chronic facial pain breakthrough: FDA clears OneRF Trigeminal Nerve Ablation System for precise, minimally invasive treatment. painmedicinenews.com/a/3DABA… #PainManagement

The FDA granted clearance to market the OneRF Trigeminal Nerve Ablation System (NeuroOne) for use in procedures to create radiofrequency (RF) lesions for the treatment of pain, or for lesioning nerve tissue for functional neurosurgical procedures.  painmedicinenews.com/a/3DABA…

The @US_FDA granted 510(k) clearance to the #OneRF Trigeminal Nerve Ablation System for the treatment of people with facial pain or for lesioning nerve tissue during neurosurgical procedures. ow.ly/v2gm50WIpEZ @N1MTC @AANmember @ahsheadache @ASRA_Society

We’re proud to share that the FDA has cleared @N1MTC's OneRF® Trigeminal Nerve Ablation System — a first-of-its-kind multi-contact RF probe technology designed to treat trigeminal neuralgia. ir.nmtc1.com/press-release-d…

$NMTC - NeuroOne Medical Technologies Corporation received FDA 510(k) clearance for its OneRF® Trigeminal Nerve Ablation System, which is designed to treat pain through radiofrequency lesions. Read more on visufinance.com/?article=384…

We also forecast huge revenue increased due to product-discovery, due to the fact that NeuroOne’s flagship offering, the OneRF™ Ablation System, holds a unique position in the epilepsy treatment market as the only FDA-cleared sEEG-guided radiofrequency (RF) platform that offers both diagnostic and therapeutic capabilities through a single electrode. This technological integration allows for streamlined procedures, which can reduce the number of surgeries required, shorten hospital stays, and even enable bedside ablations.

Furthermore, there is more to like about NMTC: Zimmer Biomet signed an exclusive distribution deal for NMTC’s FDA-cleared OneRF Ablation System, paying $3M upfront with potential for $1M in milestones. Zimmer ‘picked’ NMTC’s product to market and distribute. This led to it earning about 3 million in license revenues last quarter. However, the real surprise factor is that the product revenue increased more than 3-fold Year on Year. Insane growth which will continue under its Zimmer partnership! The revenuemay not reflect immediately, but will grow in the coming quarters. For instance, Q2 2025'S earnings showed 1.4million in product revenue, still impressive growth from previous FY 2024 numbers. Imagine the growth after full Zimmer integration!

@N1MTC had a great time at @AANSNeuro #AANS2025 in Boston! A highlight: Dr. Sanjeet Grewal’s powerful talk on his early experience with the OneRF™ Ablation System—an inspiring glimpse into the future of #epilepsy care. (RxOnly)

We are excited to be at #AANS2025 in #Boston! Visit @zimmerbiomet at booth 808 to learn about the OneRF™ Ablation System — the first FDA-cleared system for nervous tissue RF ablation with the Evo® sEEG-RF Probe. Exhibit Hall open 7AM–3:45PM today and tomorrow! @AANSNeuro